DNA methylation during human adipogenesis and the impact of fructose.
Adipocyte differentiation
DNA methylation
Differentially methylated regions
Gene expression
Integration analysis
Obesity
Journal
Genes & nutrition
ISSN: 1555-8932
Titre abrégé: Genes Nutr
Pays: Germany
ID NLM: 101280108
Informations de publication
Date de publication:
26 Nov 2020
26 Nov 2020
Historique:
received:
02
03
2020
accepted:
10
11
2020
entrez:
27
11
2020
pubmed:
28
11
2020
medline:
28
11
2020
Statut:
epublish
Résumé
Increased adipogenesis and altered adipocyte function contribute to the development of obesity and associated comorbidities. Fructose modified adipocyte metabolism compared to glucose, but the regulatory mechanisms and consequences for obesity are unknown. Genome-wide methylation and global transcriptomics in SGBS pre-adipocytes exposed to 0, 2.5, 5, and 10 mM fructose, added to a 5-mM glucose-containing medium, were analyzed at 0, 24, 48, 96, 192, and 384 h following the induction of adipogenesis. Time-dependent changes in DNA methylation compared to baseline (0 h) occurred during the final maturation of adipocytes, between 192 and 384 h. Larger percentages (0.1% at 192 h, 3.2% at 384 h) of differentially methylated regions (DMRs) were found in adipocytes differentiated in the glucose-containing control media compared to adipocytes differentiated in fructose-supplemented media (0.0006% for 10 mM, 0.001% for 5 mM, and 0.005% for 2.5 mM at 384 h). A total of 1437 DMRs were identified in 5237 differentially expressed genes at 384 h post-induction in glucose-containing (5 mM) control media. The majority of them inversely correlated with the gene expression, but 666 regions were positively correlated to the gene expression. Our studies demonstrate that DNA methylation regulates or marks the transformation of morphologically differentiating adipocytes (seen at 192 h), to the more mature and metabolically robust adipocytes (as seen at 384 h) in a genome-wide manner. Lower (2.5 mM) concentrations of fructose have the most robust effects on methylation compared to higher concentrations (5 and 10 mM), suggesting that fructose may be playing a signaling/regulatory role at lower concentrations of fructose and as a substrate at higher concentrations.
Sections du résumé
BACKGROUND
BACKGROUND
Increased adipogenesis and altered adipocyte function contribute to the development of obesity and associated comorbidities. Fructose modified adipocyte metabolism compared to glucose, but the regulatory mechanisms and consequences for obesity are unknown. Genome-wide methylation and global transcriptomics in SGBS pre-adipocytes exposed to 0, 2.5, 5, and 10 mM fructose, added to a 5-mM glucose-containing medium, were analyzed at 0, 24, 48, 96, 192, and 384 h following the induction of adipogenesis.
RESULTS
RESULTS
Time-dependent changes in DNA methylation compared to baseline (0 h) occurred during the final maturation of adipocytes, between 192 and 384 h. Larger percentages (0.1% at 192 h, 3.2% at 384 h) of differentially methylated regions (DMRs) were found in adipocytes differentiated in the glucose-containing control media compared to adipocytes differentiated in fructose-supplemented media (0.0006% for 10 mM, 0.001% for 5 mM, and 0.005% for 2.5 mM at 384 h). A total of 1437 DMRs were identified in 5237 differentially expressed genes at 384 h post-induction in glucose-containing (5 mM) control media. The majority of them inversely correlated with the gene expression, but 666 regions were positively correlated to the gene expression.
CONCLUSIONS
CONCLUSIONS
Our studies demonstrate that DNA methylation regulates or marks the transformation of morphologically differentiating adipocytes (seen at 192 h), to the more mature and metabolically robust adipocytes (as seen at 384 h) in a genome-wide manner. Lower (2.5 mM) concentrations of fructose have the most robust effects on methylation compared to higher concentrations (5 and 10 mM), suggesting that fructose may be playing a signaling/regulatory role at lower concentrations of fructose and as a substrate at higher concentrations.
Identifiants
pubmed: 33243154
doi: 10.1186/s12263-020-00680-2
pii: 10.1186/s12263-020-00680-2
pmc: PMC7691080
doi:
Types de publication
Journal Article
Langues
eng
Pagination
21Références
J Neurosci Res. 2020 Aug;98(8):1662-1668
pubmed: 32524664
FEBS Lett. 2014 Dec 20;588(24):4807-14
pubmed: 25451225
Genome Biol. 2015 May 21;16:105
pubmed: 25994056
Metabolites. 2015 Jun 16;5(2):364-85
pubmed: 26087138
Nutr J. 2014 Jun 17;13:61
pubmed: 24939238
Prog Mol Biol Transl Sci. 2010;94:291-347
pubmed: 21036330
Environ Health Perspect. 2017 Sep 14;125(9):097013
pubmed: 28934090
Toxicol In Vitro. 2017 Apr;40:79-87
pubmed: 28011154
Cell Cycle. 2016 Dec;15(23):3183-3190
pubmed: 27753528
Brief Bioinform. 2016 Sep;17(5):891-901
pubmed: 26467821
JAMA Netw Open. 2020 Jul 1;3(7):e209993
pubmed: 32644139
Adv Nutr. 2017 May 15;8(3):412-422
pubmed: 28507007
BMC Genomics. 2014 Mar 26;15:119
pubmed: 24669864
Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
F1000Res. 2013 Dec 04;2:264
pubmed: 24701342
Curr Opin Clin Nutr Metab Care. 2018 May;21(3):214-222
pubmed: 29406418
Nat Chem Biol. 2016 Jan;12(1):15-21
pubmed: 26571352
Chronobiol Int. 2012 Nov;29(9):1180-94
pubmed: 23003921
Hum Mol Genet. 2015 Aug 1;24(15):4464-79
pubmed: 25935004
N Biotechnol. 2012 Jun 15;29(5):543-9
pubmed: 22155539
J Proteome Res. 2010 Oct 1;9(10):5228-38
pubmed: 20707391
Am J Clin Nutr. 2009 Jun;89(6):1760-5
pubmed: 19403641
Genes Nutr. 2013 Jan;8(1):105-13
pubmed: 22648174
PLoS One. 2011 Mar 23;6(3):e17154
pubmed: 21448265
Trends Genet. 1999 Jan;15(1):34-7
pubmed: 10087932
Genes Dev. 2012 Jan 1;26(1):6-10
pubmed: 22215805
PLoS Med. 2008 Mar 11;5(3):e51
pubmed: 18336063
Obes Facts. 2008;1(4):184-9
pubmed: 20054179
Am J Physiol Cell Physiol. 2014 May 15;306(10):C879-86
pubmed: 24598362
Aquat Toxicol. 2016 Jul;176:116-27
pubmed: 27130971
Nutrients. 2016 Apr 02;8(4):198
pubmed: 27049396
J Proteomics. 2010 Jan 3;73(3):649-66
pubmed: 19755178
Pancreas. 2009 Aug;38(6):706-12
pubmed: 19506535
Diabetes. 2014 Sep;63(9):2962-76
pubmed: 24812430
Genome Med. 2015 Oct 08;7:103
pubmed: 26449484
Diabetes. 2012 May;61(5):1217-24
pubmed: 22447857
Nucleic Acids Res. 2013 Jun;41(11):e117
pubmed: 23598999
Eur J Clin Nutr. 2011 Jan;65(1):77-80
pubmed: 20823899
Genome Biol. 2003;4(5):P3
pubmed: 12734009
Nature. 2017 Jan 5;541(7635):81-86
pubmed: 28002404
Biomol Concepts. 2012 Aug;3(4):307-18
pubmed: 25436539
J Am Diet Assoc. 2010 Sep;110(9):1307-21
pubmed: 20800122
PLoS One. 2010 Dec 07;5(12):e15004
pubmed: 21165148
Clin Biochem. 2010 Jan;43(1-2):198-207
pubmed: 19747474
Genes Dev. 2012 Jan 1;26(1):25-30
pubmed: 22215807
J Clin Invest. 2018 Feb 1;128(2):545-555
pubmed: 29388924
Sci Rep. 2017 Jun 22;7(1):4031
pubmed: 28642596
Clin Transl Oncol. 2012 Oct;14(10):774-82
pubmed: 22855155
Mol Endocrinol. 2014 Feb;28(2):157-72
pubmed: 24295738
Trends Genet. 2015 May;31(5):274-80
pubmed: 25837375
Biochem Biophys Res Commun. 2015 May 8;460(3):684-90
pubmed: 25813485
Am J Clin Nutr. 2004 Apr;79(4):537-43
pubmed: 15051594
Mol Biol Cell. 2011 Nov;22(21):3945-54
pubmed: 21917589
Sci Rep. 2016 Apr 15;6:24540
pubmed: 27080554
Lancet. 2014 Jun 7;383(9933):1990-8
pubmed: 24630777
Metabolomics. 2015;11(3):529-544
pubmed: 25972768
J Nutr Biochem. 2014 Apr;25(4):446-55
pubmed: 24565674
Bioinformatics. 2015 Apr 1;31(7):1127-9
pubmed: 25417204
Arq Bras Endocrinol Metabol. 2014 Aug;58(6):600-9
pubmed: 25211442
Mol Cell Biol. 2019 May 14;39(11):
pubmed: 30936246
Mol Cell Oncol. 2015 Jan 30;2(1):e970480
pubmed: 27308406
J Nutr Metab. 2013;2013:682673
pubmed: 23762544
Sci Rep. 2016 Jul 07;6:28851
pubmed: 27385551
J Cell Biochem. 2016 Dec;117(12):2707-2718
pubmed: 27061314
Orphanet J Rare Dis. 2014 Sep 20;9:138
pubmed: 25238977
Gene. 2014 Sep 10;548(1):61-7
pubmed: 25010727
J Mol Biol. 2012 Oct 5;422(5):595-606
pubmed: 22721953
Stat Appl Genet Mol Biol. 2004;3:Article3
pubmed: 16646809
Cancer Cell. 2014 Oct 13;26(4):577-90
pubmed: 25263941
Nat Rev Genet. 2017 Sep;18(9):517-534
pubmed: 28555658
Nat Rev Genet. 2012 May 29;13(7):484-92
pubmed: 22641018
Diabetes. 2015 Sep;64(9):3135-45
pubmed: 25972572
Front Genet. 2014 Sep 16;5:324
pubmed: 25278959
Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):185-9
pubmed: 26519879
Genome Biol. 2012 Jun 15;13(6):R44
pubmed: 22703947
J Clin Invest. 2009 May;119(5):1322-34
pubmed: 19381015
Mol Endocrinol. 2012 Oct;26(10):1773-82
pubmed: 22827929
Nutr Metab (Lond). 2015 Jul 30;12:25
pubmed: 26225136